These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 2431092)

  • 1. Molecular localization and polymorphism of HLA class II restriction determinants defined by Mycobacterium leprae-reactive helper T cell clones from leprosy patients.
    Ottenhoff TH; Neuteboom S; Elferink DG; de Vries RR
    J Exp Med; 1986 Dec; 164(6):1923-39. PubMed ID: 2431092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA class II+ human keratinocytes present Mycobacterium leprae antigens to CD4+ Th1-like cells.
    Mutis T; De Bueger M; Bakker A; Ottenhoff TH
    Scand J Immunol; 1993 Jan; 37(1):43-51. PubMed ID: 8418472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA and leprosy in the pre and postgenomic eras.
    Geluk A; Ottenhoff TH
    Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic and functional characterization of human suppressor T-cell clones: II. Activation by Mycobacterium leprae presented by HLA-DR molecules to alpha beta T-cell receptors.
    Li SG; Elferink DG; de Vries RR
    Hum Immunol; 1990 May; 28(1):11-26. PubMed ID: 1692823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DR-restricted antigen-induced proliferation and cytotoxicity mediated by CD4+ T-cell clones from subjects vaccinated with killed M. leprae.
    Mustafa AS; Qvigstad E
    Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):1-11. PubMed ID: 2659694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic molecular analysis of the T cell-stimulating antigens from Mycobacterium leprae with T cell clones of leprosy patients. Identification of a novel M. leprae HSP 70 fragment by M. leprae-specific T cells.
    Janson AA; Klatser PR; van der Zee R; Cornelisse YE; de Vries RR; Thole JE; Ottenhoff TH
    J Immunol; 1991 Nov; 147(10):3530-7. PubMed ID: 1940353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells.
    Ottenhoff TH; Elferink DG; Klatser PR; de Vries RR
    Nature; 1986 Jul 31-Aug 6; 322(6078):462-4. PubMed ID: 2426597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA class-II-restricted Mycobacterium leprae-reactive T-cell clones from leprosy patients established with a minimal requirement for autologous mononuclear cells.
    Haanen JB; Ottenhoff TH; Voordouw A; Elferink BG; Klatser PR; Spits H; De Vries RR
    Scand J Immunol; 1986 Jan; 23(1):101-8. PubMed ID: 2422737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of HLA-DR glycoproteins by DNA-mediated gene transfer. Definition of DR2 beta gene products and antigen presentation to T cell clones from leprosy patients.
    Wilkinson D; de Vries RR; Madrigal JA; Lock CB; Morgenstern JP; Trowsdale J; Altmann DM
    J Exp Med; 1988 Apr; 167(4):1442-58. PubMed ID: 3128633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell responses to major membrane protein II (MMP II) of Mycobacterium leprae are restricted by HLA-DR molecules in patients with leprosy.
    Ohyama H; Matsushita S; Nishimura F; Kato N; Hatano K; Takashiba S; Murayama Y
    Vaccine; 2001 Nov; 20(3-4):475-82. PubMed ID: 11672912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Mycobacterium leprae-specific human T cell epitope cross-reactive with an HLA-DR2 peptide.
    Anderson DC; van Schooten WC; Barry ME; Janson AA; Buchanan TM; de Vries RR
    Science; 1988 Oct; 242(4876):259-61. PubMed ID: 2459778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
    Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
    J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycobacterium leprae-specific protein antigens defined by cloned human helper T cells.
    Ottenhoff TH; Klatser PR; Ivanyi J; Elferink DG; de Wit MY; de Vries RR
    Nature; 1986 Jan 2-8; 319(6048):66-8. PubMed ID: 2417123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-reactive epitopes and HLA-restriction elements in human T cell recognition of the Mycobacterium leprae 18-kD heat shock protein.
    Mustafa AS; Lundin KE; Meloen RH; Oftung F
    Clin Exp Immunol; 2000 Apr; 120(1):85-92. PubMed ID: 10759768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-DQ molecules and the control of Mycobacterium leprae-specific T cell nonresponsiveness in lepromatous leprosy patients.
    Ottenhoff TH; Walford C; Nishimura Y; Reddy NB; Sasazuki T
    Eur J Immunol; 1990 Oct; 20(10):2347-50. PubMed ID: 1700754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The genetic susceptibility to leprosy in humans].
    Lagrange PH; Abel L
    Acta Leprol; 1996; 10(1):11-27. PubMed ID: 8967289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
    Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
    J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DR polymorphism modulates the cytokine profile of Mycobacterium leprae HSP-reactive CD4+ T cells.
    Mitra DK; Rajalingam R; Taneja V; Bhattacharyya BC; Mehra NK
    Clin Immunol Immunopathol; 1997 Jan; 82(1):60-7. PubMed ID: 9000043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the mechanism of human T cell suppression.
    Salgame P; Modlin R; Bloom BR
    Int Immunol; 1989; 1(2):121-9. PubMed ID: 2535060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal analysis of HLA-DR and -DQ associated determinants: their contribution to Dw specificities.
    Reinsmoen NL; Bach FH
    Hum Immunol; 1986 Aug; 16(4):329-46. PubMed ID: 2428780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.